Annual Net Income
-$113.87 M
+$51.59 M+31.18%
31 December 2023
Summary:
Adaptimmune Therapeutics annual net profit is currently -$113.87 million, with the most recent change of +$51.59 million (+31.18%) on 31 December 2023. During the last 3 years, it has risen by +$16.22 million (+12.47%). ADAP annual net income is now -1245.29% below its all-time high of -$8.46 million, reached on 30 June 2013.ADAP Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$17.62 M
-$87.14 M-125.34%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly net profit is currently -$17.62 million, with the most recent change of -$87.14 million (-125.34%) on 30 September 2024. Over the past year, it has increased by +$27.98 million (+61.37%). ADAP quarterly net income is now -125.34% below its all-time high of $69.52 million, reached on 30 June 2024.ADAP Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$44.52 M
+$27.98 M+38.60%
30 September 2024
Summary:
Adaptimmune Therapeutics TTM net profit is currently -$44.52 million, with the most recent change of +$27.98 million (+38.60%) on 30 September 2024. Over the past year, it has increased by +$50.69 million (+53.24%). ADAP TTM net income is now -1408.51% below its all-time high of -$2.95 million, reached on 30 September 2015.ADAP TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.2% | +61.4% | +53.2% |
| 3 y3 years | +12.5% | +58.5% | +71.4% |
| 5 y5 years | -19.2% | +55.2% | +69.1% |
ADAP Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +31.2% | -125.3% | +65.0% | at high | +74.7% |
| 5 y | 5 years | -19.2% | +31.2% | -125.3% | +65.0% | at high | +74.7% |
| alltime | all time | -1245.3% | +31.2% | -125.3% | +65.0% | -1408.5% | +74.7% |
Adaptimmune Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.62 M(-125.3%) | -$44.52 M(-38.6%) |
| June 2024 | - | $69.52 M(-243.3%) | -$72.50 M(-55.6%) |
| Mar 2024 | - | -$48.50 M(+1.2%) | -$163.41 M(+43.5%) |
| Dec 2023 | -$113.87 M(-31.2%) | -$47.92 M(+5.1%) | -$113.87 M(+19.6%) |
| Sept 2023 | - | -$45.60 M(+113.2%) | -$95.20 M(+4.6%) |
| June 2023 | - | -$21.39 M(-2164.6%) | -$91.02 M(-20.3%) |
| Mar 2023 | - | $1.04 M(-103.5%) | -$114.16 M(-31.0%) |
| Dec 2022 | -$165.46 M(+4.7%) | -$29.25 M(-29.4%) | -$165.46 M(-5.5%) |
| Sept 2022 | - | -$41.42 M(-7.0%) | -$175.06 M(-0.6%) |
| June 2022 | - | -$44.52 M(-11.4%) | -$176.04 M(+3.2%) |
| Mar 2022 | - | -$50.27 M(+29.4%) | -$170.59 M(+7.9%) |
| Dec 2021 | -$158.09 M(+21.5%) | -$38.86 M(-8.4%) | -$158.09 M(+1.4%) |
| Sept 2021 | - | -$42.40 M(+8.5%) | -$155.84 M(+4.7%) |
| June 2021 | - | -$39.07 M(+3.5%) | -$148.88 M(+6.6%) |
| Mar 2021 | - | -$37.76 M(+3.1%) | -$139.69 M(+7.4%) |
| Dec 2020 | -$130.09 M(-5.2%) | -$36.61 M(+3.3%) | -$130.09 M(+5.9%) |
| Sept 2020 | - | -$35.43 M(+18.6%) | -$122.84 M(-3.1%) |
| June 2020 | - | -$29.88 M(+6.1%) | -$126.71 M(-8.1%) |
| Mar 2020 | - | -$28.17 M(-4.1%) | -$137.92 M(+0.6%) |
| Dec 2019 | -$137.16 M | -$29.36 M(-25.3%) | -$137.16 M(-4.7%) |
| Sept 2019 | - | -$39.30 M(-4.3%) | -$143.97 M(+44.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$41.09 M(+49.9%) | -$99.43 M(-2.7%) |
| Mar 2019 | - | -$27.41 M(-24.2%) | -$102.19 M(+6.6%) |
| Dec 2018 | -$95.51 M(+36.2%) | -$36.17 M(-790.1%) | -$95.85 M(+10.2%) |
| Sept 2018 | - | $5.24 M(-112.0%) | -$86.94 M(-6.6%) |
| June 2018 | - | -$43.84 M(+108.0%) | -$93.06 M(+34.0%) |
| Mar 2018 | - | -$21.08 M(-22.7%) | -$69.43 M(-1.0%) |
| Dec 2017 | -$70.14 M(-2.0%) | -$27.26 M(+3005.1%) | -$70.14 M(+20.3%) |
| Sept 2017 | - | -$878.00 K(-95.7%) | -$58.29 M(-23.2%) |
| June 2017 | - | -$20.21 M(-7.2%) | -$75.91 M(-2.4%) |
| Mar 2017 | - | -$21.78 M(+41.3%) | -$77.78 M(+8.7%) |
| Dec 2016 | -$71.58 M(+211.2%) | -$15.41 M(-16.7%) | -$71.58 M(+27.4%) |
| Sept 2016 | - | -$18.49 M(-16.3%) | -$56.16 M(+43.9%) |
| June 2016 | - | -$22.09 M(+41.9%) | -$39.03 M(+130.5%) |
| Mar 2016 | - | -$15.58 M(+1045.9%) | -$16.94 M(+473.9%) |
| Dec 2015 | -$23.00 M(+4.3%) | - | - |
| Sept 2015 | - | -$1.36 M(-14.6%) | -$2.95 M(-39.3%) |
| June 2015 | -$22.06 M(+90.1%) | - | - |
| Dec 2014 | - | -$1.59 M(-51.3%) | -$4.86 M(+48.7%) |
| Sept 2014 | - | -$3.27 M | -$3.27 M |
| June 2014 | -$11.60 M(+37.1%) | - | - |
| June 2013 | -$8.46 M | - | - |
FAQ
- What is Adaptimmune Therapeutics annual net profit?
- What is the all time high annual net income for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual net income year-on-year change?
- What is Adaptimmune Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly net income year-on-year change?
- What is Adaptimmune Therapeutics TTM net profit?
- What is the all time high TTM net income for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics TTM net income year-on-year change?
What is Adaptimmune Therapeutics annual net profit?
The current annual net income of ADAP is -$113.87 M
What is the all time high annual net income for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual net profit is -$8.46 M
What is Adaptimmune Therapeutics annual net income year-on-year change?
Over the past year, ADAP annual net profit has changed by +$51.59 M (+31.18%)
What is Adaptimmune Therapeutics quarterly net profit?
The current quarterly net income of ADAP is -$17.62 M
What is the all time high quarterly net income for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly net profit is $69.52 M
What is Adaptimmune Therapeutics quarterly net income year-on-year change?
Over the past year, ADAP quarterly net profit has changed by +$27.98 M (+61.37%)
What is Adaptimmune Therapeutics TTM net profit?
The current TTM net income of ADAP is -$44.52 M
What is the all time high TTM net income for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high TTM net profit is -$2.95 M
What is Adaptimmune Therapeutics TTM net income year-on-year change?
Over the past year, ADAP TTM net profit has changed by +$50.69 M (+53.24%)